Navigation Links
Allergy & Asthma Network and Avella Specialty Pharmacy Highlight Risks Associated with Latex Allergies and Latex in Healthcare
Date:3/28/2017

VIENNA, Va. and PHOENIX, March 28, 2017 /PRNewswire/ -- Today, Allergy & Asthma Network and Avella Specialty Pharmacy released a new white paper to underscore the significant risks related to latex allergies and the use of latex in healthcare. Specifically, there is substantial confusion as to the meaning of "latex free" in healthcare. In fact, the FDA has urged manufacturers to drop the term "latex free" or a "does not contain latex" claim from labels, because of the challenge to ensure a product is completely devoid of natural rubber latex proteins that cause allergic reactions. According to the FDA, these labeling techniques are not sufficiently specific, not necessarily scientifically accurate, and may be misunderstood and applied too widely.

"Patient and physician safety is our highest priority, and we're pleased to collaborate with Allergy & Asthma Network to shine a spotlight on the risks related to latex allergies and the use of latex in healthcare," said Rebecca Shanahan, CEO of Avella Specialty Pharmacy. "Working in healthcare, it is vitally important to be aware of – and prepare for – all allergies related to the medications and products we use daily. We hope this white paper will equip caregivers with the information they need to ensure their safety and the safety of their patients."

Continue Reading
Latex White Paper Cover
Latex White Paper Cover

"We commend Avella Specialty Pharmacy for its leadership around the important issue of safeguarding against adverse effects related to latex allergies and the use of latex in healthcare," said Tonya Winders, President & CEO of Allergy & Asthma Network. "When working with patients who have latex allergies, healthcare personnel must make efforts to ensure a latex-safe environment and therapy regimen. Allergy & Asthma Network is always looking for new and better ways to promote patient and healthcare professional safety, so we welcome partnerships like this with thoughtful healthcare stakeholders and pharmacies, like Avella."

Co-authors of the new white paper, entitled "Latex Free Claims: A White Paper on the Risks Associated with Latex Allergies and Latex in Healthcare," include latex allergy expert and co-founder of the former American Latex Allergy Association, Sue Lockwood, and Dr. Robert Hamilton, M.S., Ph.D. of Allergy & Asthma Network, along with Avella Specialty Pharmacy's Dr. Eric Sredzinski, Pharm.D., AAHIVP, and Dr. Jenna Vaughn, Pharm.D., PGY1.

To download the white paper, please visit: www.avella.com/latex

About Avella Specialty Pharmacy
Headquartered in Phoenix, Arizona, Avella is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2016, Avella was named Specialty Pharmacy of the Year by NASP, a nationally recognized pharmacy trade committee. Inc. Magazine's 2016 list of the 5,000 fastest-growing private companies in the country included Avella for the tenth consecutive year and also recognized Avella as the fastest-growing woman-led company in 2015. In addition, the Arizona Corporate Excellence Awards named Avella Specialty Pharmacy as the second fastest-growing private company based in the state in 2015. For more information, please visit www.avella.com.

About Allergy & Asthma Network
Allergy & Asthma Network is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. Allergy & Asthma Network specializes in sharing family-friendly, medically accurate information through its award-winning magazine Allergy & Asthma Today, E-newsletter, AllergyAsthmaNetwork.org and numerous community outreach programs. Follow Allergy & Asthma Network on Facebook and Twitter @AllergyAsthmaHQ. Join the Network at AllergyAsthmaNetwork.org/join.

Media Contact


Maureen Shanahan  

Chris Thatcher

mshanahan@skdknick.com 

cthatcher@5wpr.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/allergy--asthma-network-and-avella-specialty-pharmacy-highlight-risks-associated-with-latex-allergies-and-latex-in-healthcare-300430641.html


'/>"/>
SOURCE Avella Specialty Pharmacy
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Allergies: standardisation, regulation and clinical trials breakthroughs with Stallergenes Greer, HAL Allergy, Nestle & LETI
2. Global Allergy Partnering 2010 to 2017
3. CSRAs DynPort Vaccine Company to Help Advance Medical Products for the National Institute of Allergy and Infectious Diseases
4. Five Things to Know About Penicillin Allergy
5. Allergy Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
6. Tolerability Data for Shires CUVITRU Accepted for Oral Presentation at the American College Of Allergy, Asthma & Immunology Annual Meeting
7. New Hospital Guidelines: Assess Penicillin Allergy To Ensure Optimal Antibiotic Use
8. Penicillin Allergy Is Overstated
9. Indiana Voters Oppose Prescription Requirements for Popular Cold and Allergy Medicines
10. Global Immunoprotein Diagnostic Testing Market 2015-2019 - Infectious Disease, Oncology and Endocrine, Autoimmune & Allergy Testing
11. How Penicillin Allergy Skin Testing Helps Combat A Growing Public Health Threat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
Breaking Medicine News(10 mins):